Chem Abst. 98 (1983)--46600x, Bertele et al. |
Chem Abst. 108 (1988)--180111s, Arai. |
Chem Abst. 110 (1989)--141529f, McKie et al. |
Chem Abst. 111 (1989)--89965Z, Danesh et al. |
Chest, vol. 95, No. 2, Feb. 1989, J. Hirsh et al.: Aspirin and other platelet active drugs--Relationship among dose, effectiveness, and side effects, pp. 12S-18S. |
Japanese Pharmacology & Therapeutics, Yakuri to Chiryo, vol. 16, No. 1, Jan. 1988, S.-I. Naito et al.: Percutaneous absorption of salicylic acid derivatives, pp. 17-25. |
J.E.F. Reynolds et al.: Martindale the Extra Pharmacopoeia, 29.sup.th Ed., 1989, pp. 3-8, The Pharmaceutical Press, London GB. |
The Journal of Burn Care & Rehabilitation, vol. 6, No. 6, Nov./Dec. 1985, J.P. Heggers et al.: Thromboxane inhibitors for the prevention of progressive dermal ischemia due to the thermal injury, pp. 466-468. |
The Journal of Clinical Investigation, vol. 69, No. 6, Jun. 1982, P. Patrignani et al.: Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects, pp. 1366-1372. |
New England Journal of Medicine, vol. 325, 1991, Thun et al.: Aspirin Use and Reduced Risk of Fatal Colon Cancer, pp. 1593-1596. |
Van Moorleghem G L, Derwent WPI, Derwent Publications, Ltd., Week 7647, WPI Acc No: 76-87300X (Abstract of French Patent Application No. 2,297,612, Sep. 17, 1976). |
Teisan Seiyaku, Derwent WPI, Derwent Publications, Ltd., Week 8636, WPI Acc No: 86-236772 (Abstract of Japanese Patent Application No. 61-167615, Jul. 29, 1986). |
Teikoku Seiyaku, Derwent WPI, Derwent Publications, Ltd., Week 8939, WPI Acc No: 89-280859 (Abstract of Japanese Patent Application No. 1-203336, Aug. 16, 1989). |
Nikko Chemicals, Derwent WPI, Derwent Publications, Ltd., Week 8945, WPI Acc No: 89-327620 (Abstract of Japanese Patent Application No. 1-242521, Sep. 27, 1989). |
Kyowa Hakko Kogyo, Derwent WPI, Derwent Publications, Ltd., Week 9125, WPI Acc No: 91-183201 (Abstract of Japanese Patent Application No. 3-112926, May 14, 1991). |